Form 4: Chimera Investment Director Susan Mills Receives Significant RSU Grant

Chimera Investment Corporation Director Susan Mills was granted 9,685 restricted stock units (RSUs) on June 10, 2025, increasing her direct beneficial ownership to 21,015 shares.

Summary

• Susan Mills, a Director of Chimera Investment Corporation (CIM), acquired 9,685 shares of common stock on June 10, 2025.
• These shares represent restricted stock units (RSUs) granted to her as part of her compensation.
• The RSUs were acquired at a price of $0, indicating a grant rather than a purchase.
• Following this transaction, Susan Mills' direct beneficial ownership in Chimera Investment Corporation increased to 21,015 shares.
• The RSUs are scheduled to vest on the earlier of June 10, 2026 (the first anniversary of the grant date) or the date of the next annual stockholders meeting of the Company.
• Upon vesting, the RSUs will be settled 100% in shares of Chimera common stock.

Sentiment

Score: 7

Explanation: The grant of RSUs to a director is generally a positive signal, aligning interests and showing commitment, though it's a routine compensation event rather than a major strategic announcement that would significantly alter the company's outlook.

Positives

• The grant of restricted stock units to a director aligns her interests with shareholders, as the value of the grant is directly tied to the company's stock performance.
• An increase in beneficial ownership by a director, even through a grant, can be viewed as a sign of confidence in the company's future prospects.

Risks

• The ultimate value of the granted RSUs to the reporting person is dependent on the future market price of Chimera Investment Corporation's common stock.
• Vesting of the RSUs is contingent on Susan Mills' continued service as a director until the specified vesting date or the next annual stockholders meeting.

Future Outlook

The vesting of the granted restricted stock units is tied to future dates, specifically the first anniversary of the grant date (June 10, 2026) or the date of the next annual stockholders meeting, indicating a future commitment and potential increase in the director's direct shareholding upon vesting.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a compensation grant to a director. Such equity-based grants are common practice in the financial services industry, particularly for Real Estate Investment Trusts (REITs) like Chimera Investment Corporation, to align management and director incentives with shareholder interests and long-term company performance. This filing reflects standard corporate governance and compensation practices rather than broader industry trends.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as a component of director compensation is a widely adopted practice across publicly traded companies, including those within the financial sector and REITs.
• This method of compensation is consistent with structures observed in peer companies such as Annaly Capital Management (NLY) or AGNC Investment Corp. (AGNC), which also utilize equity-based awards to incentivize their executives and directors.
• The specific volume of units granted would typically be benchmarked against compensation data for a defined peer group, although this document does not provide such comparative analysis.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the director's financial interests with long-term shareholder value through equity ownership.
• Employees: No direct impact on general employees is mentioned in this filing.

Next Steps

• Vesting of the restricted stock units on the earlier of June 10, 2026, or the date of the next annual stockholders meeting.
• Settlement of the vested RSUs into shares of Chimera common stock.

Key Dates

Recommendation

Keywords

Chimera Investment Corporation, CIM, Form 4, SEC filing, insider transaction, restricted stock units, RSU grant, director compensation, beneficial ownership